Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001882764-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
6,018
Total Value
$352,551.17
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Aug 17, 2026 | Sale | 4,630 | $58.35 | $270,168.37 | 41,424 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Aug 17, 2026 | Sale | 1,388 | $59.35 | $82,382.80 | 40,036 | Direct | โ | View Details |